Vitamin D and outcomes in adult critically ill patients. A systematic review and meta-analysis of randomized trials

Journal of Critical Care

Volumn 38, Issue , 2017, Pages 109-114

  Putzu, Alessandro ^a   Belletti, Alessandro ^b   Cassina, Tiziano ^a   Clivio, Sara ^a   Monti, Giacomo ^b   Zangrillo, Alberto ^b,c   Landoni, Giovanni ^b,c  

^a DIVISION OF CARDIOLOGY   (Switzerland)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Critical care; Critical illness; Mortality; Survival; Vitamin D

Indexed keywords

PLACEBO; VITAMIN D;

ARTIFICIAL VENTILATION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DRUG SAFETY; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; DIETARY SUPPLEMENT; INTENSIVE CARE;

CRITICAL CARE; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; HUMANS; INTENSIVE CARE UNITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 85013629403     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2016.10.029     Document Type: Review

References (62)

1. [1] National Institute for Health and Care Excellence, Vitamin D: increasing supplement use in at-risk groups—guidance and guidelines. 2014, NICE [ https://www.nice.org.uk/guidance].
2. [2] Gahche, J., Bailey, R., Burt, V., Hughes, J., Yetley, E., Dwyer, J., et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). NCHS Data Brief, 2011, 1–8.
3. [3] Bikle, D.D., Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21 (2014), 319–329, 10.1016/j.chembiol.2013.12.016.
4. [4] Thacher, T.D., Clarke, B.L., Vitamin D insufficiency. Mayo Clin Proc 86 (2011), 50–60, 10.4065/mcp.2010.0567.
5. [5] Amrein, K., Zajic, P., Schnedl, C., Waltensdorfer, A., Fruhwald, S., Holl, A., et al. Vitamin D status and its association with season, hospital, and sepsis mortality in critical illness. Crit Care, 18, 2014, R47, 10.1186/cc13790.
6. [6] Nair, P., Lee, P., Reynolds, C., Nguyen, N.D., Myburgh, J., Eisman, J.A., et al. Significant perturbation of vitamin D-parathyroid-calcium axis and adverse clinical outcomes in critically ill patients. Intensive Care Med 39 (2013), 267–274, 10.1007/s00134-012-2713-y.
7. [7] Lee, P., Eisman, J.A., Center, J.R., Vitamin D deficiency in critically ill patients. N Engl J Med 360 (2009), 1912–1914, 10.1056/NEJMc0809996.
8. [8] Aygencel, G., Turkoglu, M., Tuncel, A.F., Candır, B.A., Bildacı, Y.D., Pasaoglu, H., Is vitamin D insufficiency associated with mortality of critically ill patients?. Crit Care Res Pract, 2013, 2013, 856747, 10.1155/2013/856747.
9. [9] Autier, P., Boniol, M., Pizot, C., Mullie, P., Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2 (2014), 76–89, 10.1016/S2213-8587(13)70165-7.
10. [10] Zhang, Y.-P., Wan, Y.-D., Sun, T.-W., Kan, Q.-C., Wang, L.-X., Association between vitamin D deficiency and mortality in critically ill adult patients: a meta-analysis of cohort studies. Crit Care, 18, 2014, 684, 10.1186/s13054-014-0684-9.
11. [11] Rech, M.A., Hunsaker, T., Rodriguez, J., Deficiency in 25-hydroxyvitamin D and 30-day mortality in patients with severe sepsis and septic shock. Am J Crit Care 23 (2014), e72–e79, 10.4037/ajcc2014723.
12. [12] Nguyen, H.B., Eshete, B., Lau, K.H.W., Sai, A., Villarin, M., Baylink, D., Serum 1,25-dihydroxyvitamin D: an outcome prognosticator in human sepsis. PLoS One, 8, 2013, e64348, 10.1371/journal.pone.0064348.
13. [13] Venkatram, S., Chilimuri, S., Adrish, M., Salako, A., Patel, M., Diaz-Fuentes, G., Vitamin D deficiency is associated with mortality in the medical intensive care unit. Crit Care, 15, 2011, R292, 10.1186/cc10585.
14. [14] Upala, S., Sanguankeo, A., Permpalung, N., Significant association between vitamin D deficiency and sepsis: a systematic review and meta-analysis. BMC Anesthesiol, 15, 2015, 84, 10.1186/s12871-015-0063-3.
15. [15] Sriram, K., Perumal, K., Alemzadeh, G., Osei, A., Voronov, G., The relationship between immediate preoperative serum 25-hydroxy-vitamin D3 levels and cardiac function, dysglycemia, length of stay, and 30-d readmissions in cardiac surgery patients. Nutrition 31 (2015), 820–826, 10.1016/j.nut.2014.11.022.
16. [16] Taylor, C.L., Yaktine, A.L., Del Valle, H.B., Institute of Medicine (US) committee to review dietary reference intakes for vitamin D and calcium. Ross, A.C., (eds.) Overview of vitamin D, 2011, 10.17226/13050.
17. [17] Peterson, C.A., Heffernan, M.E., Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm (Lond), 5, 2008, 10, 10.1186/1476-9255-5-10.
18. [18] Krishnan, A., Ochola, J., Mundy, J., Jones, M., Kruger, P., Duncan, E., et al. Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients. Crit Care, 14, 2010, R216, 10.1186/cc9341.
19. [19] Bang, U.C., Novovic, S., Andersen, A.M., Fenger, M., Hansen, M.B., Jensen, J.-E.B., Variations in serum 25-hydroxyvitamin D during acute pancreatitis: an exploratory longitudinal study. Endocr Res 36 (2011), 135–141, 10.3109/07435800.2011.554937.
20. [20] Mullins, P.M., Goyal, M., Pines, J.M., National growth in intensive care unit admissions from emergency departments in the United States from 2002 to 2009. Acad Emerg Med 20 (2013), 479–486, 10.1111/acem.12134.
21. [21] Christopher, K.B., Vitamin D supplementation in the ICU patient. Curr Opin Clin Nutr Metab Care 18 (2015), 187–192, 10.1097/MCO.0000000000000147.
22. [22] Amrein, K., Schnedl, C., Holl, A., Riedl, R., Christopher, K.B., Pachler, C., et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA 312 (2014), 1520–1530, 10.1001/jama.2014.13204.
23. [23] Zheng, Y., Zhu, J., Zhou, M., Cui, L., Yao, W., Liu, Y., Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS One, 8, 2013, e82109, 10.1371/journal.pone.0082109.
24. [24] Keum, N., Giovannucci, E., Vitamin D supplements and cancer incidence and mortality: a meta-analysis. Br J Cancer 111 (2014), 976–980, 10.1038/bjc.2014.294.
25. [25] Bjelakovic, G., Gluud, L.L., Nikolova, D., Whitfield, K., Wetterslev, J., Simonetti, R.G., et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev, 1, 2014, CD007470, 10.1002/14651858.CD007470.pub3.
26. [26] Higgins, J.P., Green, S., Cochrane handbook for systematic reviews of interventions. Version 5. 2011, The Cochrane Collaboration.
27. [27] Friedrich, J.O., Adhikari, N.K.J., Beyene, J., Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol, 7, 2007, 5, 10.1186/1471-2288-7-5.
28. [28] Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P.A., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 339, 2009, b2700, 10.1136/bmj.b2700.
29. [29] Review Manager (RevMan) [computer program] version 5.3. 2012, The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen.
30. [30] Gottschlich, M.M., Mayes, T., Khoury, J., Kagan, R.J., Clinical trial of vitamin D2 vs D3 supplementation in critically ill pediatric burn patients. JPEN J Parenter Enteral Nutr, 2015, 10.1177/0148607115587948.
31. [31] Manaseki-Holland, S., Qader, G., Isaq Masher, M., Bruce, J., Zulf Mughal, M., Chandramohan, D., et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health 15 (2010), 1148–1155, 10.1111/j.1365-3156.2010.02578.x.
32. [32] Choudhary, N., Gupta, P., Vitamin D supplementation for severe pneumonia—a randomized controlled trial. Indian Pediatr 49 (2012), 449–454, 10.1007/s13312-012-0073-x.
33. [33] Mayes, T., Gottschlich, M.M., Khoury, J., Kagan, R.J., Investigation of bone health subsequent to vitamin D supplementation in children following burn injury. Nutr Clin Pract 30 (2015), 830–837, 10.1177/0884533615587720.
34. [34] Hanson, C., Lyden, E., Nelson, A., Thoene, M., Wagner, J., Wu, A., et al. Response of vitamin D binding protein and free vitamin D concentrations to vitamin D supplementation in hospitalized premature infants. J Pediatr Endocrinol Metab 28 (2015), 1107–1114, 10.1515/jpem-2015-0089.
35. [35] Amrein, K., Schnedl, C., Holl, A., Riedl, R., Pachler, C., Pieber, T.R., et al. Correction of vitamin D deficiency in critically ill patients: a randomized placebo-controlled trial. Clin Nutr, 33, 2014, S13, 10.1016/S0261-5614(14)50030-1.
36. [36] Quraishi, S., DePascale, G., Needleman, J., Camargo, C.J., Ednan, B., Bhan, et al. Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis. Crit Care Med, 42, 2014 [Oral Abstract Session: Sepsis].
37. [37] Perry-Walker, K., Walker, D.I., Alvarez, J.A., Han, J.E., Jones, J.L., Hao, L., et al. Impact of vitamin D status and high-dose vitamin D3 administration on the plasma metabolome in critically ill adults. FASEB J, 30, 2016, 271.3.
38. [38] Jones, J., Alvarez, J., Han, J., Hao, L., Chiang, E., Brown, L., et al. Effect of high-dose vitamin D on antimicrobial peptides in ventilator-dependent critically ill patients. FASEB J, 29, 2015, 920.3.
39. [39] Han, E.J., Jones, J.L., Brown, M., Tangpricha, V., Brown, L.A., Li, H., et al. A pilot randomized controlled trial of high-dose vitamin D in lung failure. Am Thorac Soc Int Conf Meet Abstr, 2015.
40. [40] Dickerson, R.N., Berry, S.C., Ziebarth, J.D., Swanson, J.M., Maish, G.O., Minard, G., et al. Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness. Nutrition 31 (2015), 1219–1223, 10.1016/j.nut.2015.03.008.
41. [41] Van den Berghe, G., Van Roosbroeck, D., Vanhove, P., Wouters, P.J., De Pourcq, L., Bouillon, R., Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 88 (2003), 4623–4632, 10.1210/jc.2003-030358.
42. [42] Mata-Granados, J.M., Vargas-Vasserot, J., Ferreiro-Vera, C., Luque de Castro, M.D., Pavón, R.G., Quesada Gómez, J.M., Evaluation of vitamin D endocrine system (VDES) status and response to treatment of patients in intensive care units (ICUs) using an on-line SPE-LC–MS/MS method. J Steroid Biochem Mol Biol 121 (2010), 452–455, 10.1016/j.jsbmb.2010.03.078.
43. [43] Vargas-Vasserot, J., Mata-Granados, J.M., Luque de Castro, M., Guerrero Pavón, R., Quesada Gomez, J., 25-hydroxyvitamin D3 treatment normalize the vitamin D status and the innate immune response mediated by cathelicidin in critically ill patients. Bone 48 (2011), S146–S147, 10.1016/j.bone.2011.03.310.
44. [44] Ingels, C., Van Cromphaut, S., Wouters, P., Moller, H., Van Herck, E., Jans, I., et al. Effect of restoration of 25OHD3 status in prolonged critical illness on serum innate immunity parameters LL-37 and sCD163. Crit Care, 14, 2010, P590, 10.1186/cc8822.
45. [45] Nair, P., Venkatesh, B., Lee, P., Kerr, S., Hoechter, D.J., Dimeski, G., et al. A randomized study of a single dose of intramuscular cholecalciferol in critically ill adults. Crit Care Med 43 (2015), 2313–2320, 10.1097/CCM.0000000000001201.
46. [46] Leaf, D.E., Raed, A., Donnino, M.W., Ginde, A.A., Waikar, S.S., Randomized controlled trial of calcitriol in severe sepsis. Am J Respir Crit Care Med 190 (2014), 533–541, 10.1164/rccm.201405-0988OC.
47. [47] Quraishi, S.A., De Pascale, G., Needleman, J.S., Nakazawa, H., Kaneki, M., Bajwa, E.K., et al. Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: a randomized, placebo-controlled trial. Crit Care Med 43 (2015), 1928–1937, 10.1097/CCM.0000000000001148.
48. [48] Amrein, K., Sourij, H., Wagner, G., Holl, A., Pieber, T.R., Smolle, K.H., et al. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study. Crit Care, 15, 2011, R104, 10.1186/cc10120.
49. [49] Grossmann, R.E., Zughaier, S.M., Kumari, M., Seydafkan, S., Lyles, R.H., Liu, S., et al. Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: a randomized, controlled trial. Dermatoendocrinol 4 (2012), 191–197, 10.4161/derm.20332.
50. [50] Alizadeh, N., Khalili, H., Mohammadi, M., Abdollahi, A., Ala, S., Effect of vitamin D on stress-induced hyperglycaemia and insulin resistance in critically ill patients. Int J Clin Pract, 2016, 10.1111/ijcp.12795.
51. [51] Han, J.E., Jones, J.L., Tangpricha, V., Brown, M.A., Hao, L., Hebbar, G., et al. High dose vitamin D administration in ventilated intensive care unit patients: a pilot double blind randomized controlled trial. J Clin Transl Endocrinol 4 (2016), 59–65, 10.1016/j.jcte.2016.04.004.
52. [52] White, J.H., Vitamin D metabolism and signaling in the immune system. Rev Endocr Metab Disord 13 (2012), 21–29, 10.1007/s11154-011-9195-z.
53. [53] Joseph, R.W., Bayraktar, U.D., Kim, T.K., St John, L.S., Popat, U., Khalili, J., et al. Vitamin D receptor upregulation in alloreactive human T cells. Hum Immunol 73 (2012), 693–698, 10.1016/j.humimm.2012.04.019.
54. [54] Koeffler, H.P., Amatruda, T., Ikekawa, N., Kobayashi, Y., DeLuca, H.F., Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res 44 (1984), 5624–5628.
55. [55] Liu, P.T., Stenger, S., Li, H., Wenzel, L., Tan, B.H., Krutzik, S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006), 1770–1773, 10.1126/science.1123933.
56. [56] Higgins, D.M., Wischmeyer, P.E., Queensland, K.M., Sillau, S.H., Sufit, A.J., Heyland, D.K., Relationship of vitamin D deficiency to clinical outcomes in critically ill patients. JPEN J Parenter Enteral Nutr 36 (2012), 713–720, 10.1177/0148607112444449.
57. [57] Quraishi, S.A., Bittner, E.A., Blum, L., McCarthy, C.M., Bhan, I., Camargo, C.A., Prospective study of vitamin D status at initiation of care in critically ill surgical patients and risk of 90-day mortality. Crit Care Med 42 (2014), 1365–1371, 10.1097/CCM.0000000000000210.
58. [58] Schöttker, B., Jorde, R., Peasey, A., Thorand, B., Jansen, E.H.J.M., de Groot, L., et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ, 348, 2014, g3656, 10.1136/bmj.g3656.
59. [59] de Paula, F.J.A., Rosen, C.J., Vitamin D safety and requirements. Arch Biochem Biophys 523 (2012), 64–72, 10.1016/j.abb.2011.12.002.
60. [60] Hathcock, J.N., Shao, A., Vieth, R., Heaney, R., Risk assessment for vitamin D. Am J Clin Nutr 85 (2007), 6–18.
61. [61] Rombeau, J.L., Takala, J., Summary of round table conference: gut dysfunction in critical illness. Intensive Care Med 23 (1997), 476–479, 10.1007/s001340050361.
62. [62] Heyland, D.K., Tougas, G., King, D., Cook, D.J., Impaired gastric emptying in mechanically ventilated, critically ill patients. Intensive Care Med 22 (1996), 1339–1344, 10.1007/BF01709548.